TABLE 3. Recommended meningococcal vaccines for persons at increased risk for meningococcal disease — Advisory Committee on Immunization Practices, United States, 2020.

Risk group	MenACWY vaccine	MenB vaccine	Table
Persons with complement component deficiency (e.g., C5–C9, properdin, factor H, or factor D), including patients using a complement inhibitor	Aged ≥2 mos	Aged ≥10 yrs	4
Persons with functional or anatomic asplenia (including sickle cell disease)	Aged ≥2 mos	Aged ≥10 yrs	5
Persons with HIV infection	Aged ≥2 mos	No recommendation	6
Microbiologists routinely exposed to Neisseria meningitidis	Age appropriate*	Age appropriate†	7
Persons exposed during an outbreak of meningococcal disease due to a vaccine-preventable serogroup	Aged ≥2 mos	Aged ≥10 yrs	8
Persons who travel to or live in countries where meningococcal disease is hyperendemic or epidemic	Aged ≥2 mos	No recommendation	9
College freshmen living in residence halls	Age appropriate*	No recommendation	10
Military recruits	Age appropriate*	No recommendation	10

Abbreviations: HIV = human immunodeficiency virus; MenACWY = meningococcal groups A, C, W, and Y; MenB = meningococcal group B.

* Persons aged ≥2 months in these risk groups are recommended to receive MenACWY vaccination.

^† Persons aged ≥10 years in this risk group are recommended to receive MenB vaccination.